Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
The water needs to run through the powder many times to fully dissolve it
Separation by time of day prevents problematic interactions
Grain market advisory services are offered by FBN CM LLC and are only available where FBN CM LLC is licensed
Talk to a real person or sign up for early access to new compounds
US$ 22.39
US$ 27.10
US$ 27.29
US$ 24.66
US$ 26.79
